We are live on ! Find out more
CLMT icon

Calumet Specialty Products

72 hedge funds and large institutions have $31.7M invested in Calumet Specialty Products in 2017 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 27 increasing their positions, 19 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 6

42% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 19

6% more funds holding

Funds holding: 6872 (+4)

5% more capital invested

Capital invested by funds: $30.1M → $31.7M (+$1.54M)

0.62% less ownership

Funds ownership: 10.34%9.72% (-0.62%)

65% less call options, than puts

Call options by funds: $708K | Put options by funds: $2.05M

Holders
72
Holders Change
+4
Holders Change %
+5.88%
% of All Funds
1.79%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
10
Increased
27
Reduced
19
Closed
6
Calls
$708K
Puts
$2.05M
Net Calls
-$1.34M
Net Calls Change
-$1.57M

CLMT Hedge Fund Activity: Q2 2017 in Review

72 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Calumet Specialty Products (CLMT) for Q2 2017, worth a combined $31.7M — up 5.1% from $30.1M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new CLMT positions and 6 closed out — a net gain of 4 holders — while 27 added to existing stakes and 19 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $571K. The largest seller was Citigroup, cutting an estimated $2.66M.

  • 72 institutional investors held Calumet Specialty Products (CLMT) as of Q2 2017, up from 68 in Q1 2017.
  • Funds reported $31.7M of Calumet Specialty Products stock for Q2 2017, up 5.1% quarter-over-quarter.
  • 10 funds opened new Calumet Specialty Products positions in Q2 2017 and 6 closed out, a net change of +4 holders.
  • The largest Calumet Specialty Products buyer in Q2 2017 was Morgan Stanley, an estimated $571K added.
  • The largest Calumet Specialty Products seller in Q2 2017 was Citigroup, an estimated $2.66M sold.

Based on aggregated 13F filings for Q2 2017.